Discover
ESLA
Estrella Immunopharma, Inc.
0.41
3 x 0.37
2 x 0.75
bid
ask
-
0.01
1.80%
3 @ 07:36 PM
0.35 -0.06 (14.63%)
| Ytd | -73.72% | |
| 1y | -66.67% |
0.31
day range
0.44
0.41
52 week range
3.05
| Open | 0.35 | Prev Close | 0.42 | Low | 0.31 | High | 0.44 | Mkt Cap | 17.83M |
| Vol | 19.85M | Avg Vol | 38.61K | EPS | -0.25 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.24 | Short Ratio | 0.07 | Inst. Own | 0.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.63 | 200-d Avg | 1.05 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.08M | ||
| Research and Development Expense | 1.40M | ||
| Selling, General and Administrative Expense | 684.02K | ||
| Operating Income | -2.08M | ||
| Net Income | -2.31M | ||
| Net Income Common Stock | -2.31M | ||
| Net Income Common Stock (USD) | -2.31M | ||
| Consolidated Income | -2.31M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -2.31M | ||
| Earning Before Interest & Taxes (USD) | -2.31M | ||
| Weighted Average Shares | 43.00M | ||
| Weighted Average Shares Diluted | 43.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 146.67K | ||
| Cash and Equivalents (USD) | 146.67K | ||
| Current Assets | 1.82M | ||
| Total Assets | 1.82M | ||
| Current Liabilities | 9.26M | ||
| Total Liabilities | 9.26M | ||
| Accumulated Retained Earnings (Deficit) | -41.59M | ||
| Shareholders Equity | -7.43M | ||
| Shareholders Equity (USD) | -7.43M | ||
| Trade and Non-Trade Payables | 8.23K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 4.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.78M | ||
| Issuance (Purchase) of Equity Shares | 4.00 | ||
| Net Cash Flow from Operations | -1.78M | ||
| Share Based Compensation | 145.30K | ||